<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="(INS), [2], grid.5342.00000 0001 2069 7798Department of Public Health and" exact="Primary" post="Care, Faculty of Medicine and Health Sciences, Ghent University,"/>
 <result pre="Abstract Background There is scare information about HIV co-infections with" exact="hepatitis" post="B virus (HBV) and/or hepatitis C virus (HCV) among"/>
 <result pre="information about HIV co-infections with hepatitis B virus (HBV) and/or" exact="hepatitis C" post="virus (HCV) among People Who Inject Drugs (PWID) in"/>
 <result pre="critical to ensure the treatment necessary to decrease the progression" exact="of liver" post="disease and the transmission of both HIV and hepatitis."/>
 <result pre="to ensure the treatment necessary to decrease the progression of" exact="liver disease" post="and the transmission of both HIV and hepatitis. We"/>
 <result pre="ensure the treatment necessary to decrease the progression of liver" exact="disease" post="and the transmission of both HIV and hepatitis. We"/>
 <result pre="strategy for both viruses. Keywords People who inject drugs HIV" exact="Hepatitis" post="B Hepatitis C Co-infections Respondent driven sampling Mozambique Funding"/>
 <result pre="both viruses. Keywords People who inject drugs HIV Hepatitis B" exact="Hepatitis" post="C Co-infections Respondent driven sampling Mozambique Funding http://dx.doi.org/10.13039/100009054U.S. Presidentâ€™s"/>
 <result pre="who Inject Drugs (PWID) are among the most vulnerable to" exact="HIV infection," post="with an estimated prevalence of 17.8% globally and 8.3%"/>
 <result pre="estimated prevalence of 17.8% globally and 8.3% in the Sub-Saharan" exact="African" post="region [1]. PWID are considered a key population for"/>
 <result pre="epidemic in the country [6, 7],. In addition to HIV," exact="viral hepatitis" post="remains an important global health issue, characterized by high"/>
 <result pre="in the country [6, 7],. In addition to HIV, viral" exact="hepatitis" post="remains an important global health issue, characterized by high"/>
 <result pre="morbidity and mortality, and suboptimal diagnosis and management approaches [8â€&quot;10]." exact="Viral hepatitis" post="are the most common viral infections affecting PWIDs [10,"/>
 <result pre="and mortality, and suboptimal diagnosis and management approaches [8â€&quot;10]. Viral" exact="hepatitis" post="are the most common viral infections affecting PWIDs [10,"/>
 <result pre="and management approaches [8â€&quot;10]. Viral hepatitis are the most common" exact="viral" post="infections affecting PWIDs [10, 11]. HIV and viral hepatitis"/>
 <result pre="management approaches [8â€&quot;10]. Viral hepatitis are the most common viral" exact="infections" post="affecting PWIDs [10, 11]. HIV and viral hepatitis infections"/>
 <result pre="most common viral infections affecting PWIDs [10, 11]. HIV and" exact="viral hepatitis" post="infections share common transmission routes, risk behaviors and their"/>
 <result pre="common viral infections affecting PWIDs [10, 11]. HIV and viral" exact="hepatitis" post="infections share common transmission routes, risk behaviors and their"/>
 <result pre="viral infections affecting PWIDs [10, 11]. HIV and viral hepatitis" exact="infections" post="share common transmission routes, risk behaviors and their co-infection"/>
 <result pre="concern resulting in high morbidity and mortality rates [11, 12]." exact="HIV infection" post="affects the natural course of hepatitis B virus (HBV)"/>
 <result pre="resulting in high morbidity and mortality rates [11, 12]. HIV" exact="infection" post="affects the natural course of hepatitis B virus (HBV)"/>
 <result pre="rates [11, 12]. HIV infection affects the natural course of" exact="hepatitis" post="B virus (HBV) and hepatitis C virus (HCV), promoting"/>
 <result pre="affects the natural course of hepatitis B virus (HBV) and" exact="hepatitis C" post="virus (HCV), promoting faster progression to chronicity, liver fibrosis,"/>
 <result pre="and hepatitis C virus (HCV), promoting faster progression to chronicity," exact="liver fibrosis," post="and malignancy [2, 9â€&quot;11]. The BBS among PWID in"/>
 <result pre="HBV and HCV among the general population in Mozambique is" exact="limited" post="to a few studies in the southern region of"/>
 <result pre="country [13, 14]. Global health targets to reduce HIV and" exact="viral hepatitis" post="infections have been established [15, 16]. Strengthening the prevention"/>
 <result pre="[13, 14]. Global health targets to reduce HIV and viral" exact="hepatitis" post="infections have been established [15, 16]. Strengthening the prevention"/>
 <result pre="14]. Global health targets to reduce HIV and viral hepatitis" exact="infections" post="have been established [15, 16]. Strengthening the prevention and"/>
 <result pre="been established [15, 16]. Strengthening the prevention and treatment of" exact="substance abuse," post="including narcotic drug abuse, is listed as one of"/>
 <result pre="Strengthening the prevention and treatment of substance abuse, including narcotic" exact="drug abuse," post="is listed as one of the priorities of the"/>
 <result pre="that the prevention of HIV in PWID will also prevent" exact="hepatitis" post="given their similar modes of transmission and high-risk populations."/>
 <result pre="response in the country. As such, the objective of this" exact="secondary" post="analysis was to evaluate HIV/HBV and HIV/HCV co-infections among"/>
 <result pre="continues to be lack of integrated services for HIV and" exact="viral hepatitis." post="Since Mozambique has one of the highest HIV prevalence"/>
 <result pre="results of the rapid HIV tests, together with self-reported prior" exact="HIV-positive" post="test results, were used to estimate HIV prevalence. On-site"/>
 <result pre="respectively; none of the tests were able to determine if" exact="infection" post="was acute or chronic. Participants with positive results for"/>
 <result pre="of the tests were able to determine if infection was" exact="acute" post="or chronic. Participants with positive results for any of"/>
 <result pre="the tests were able to determine if infection was acute" exact="or chronic." post="Participants with positive results for any of the laboratory"/>
 <result pre="ready to link them to treatment services [6, 7]. Dried" exact="Blood" post="Spot (DBS) were also collected and analyzed at the"/>
 <result pre="of the bivariate association (pâ€‰ Ethical considerations This is a" exact="secondary" post="data analysis from a survey protocol that was approved"/>
 <result pre="of California at San Francisco (13â€&quot;10,699); the US Centers for" exact="Disease" post="Control and Prevention (CDC) determined the protocol to be"/>
 <result pre="no personal identifying information was collected. Results Population characteristics A" exact="total" post="of 353 PWID were enrolled in the survey in"/>
 <result pre="median age was 32â€‰years. Half (49.9, 95%CI: 42.8â€&quot;55.9) had completed" exact="secondary" post="or higher education. The majority of participants were Christian"/>
 <result pre="HBsAg among PWID was 32.8% (95%CI: 26.3â€&quot;39.5) and 38.3% for" exact="hepatitis C" post="virus antibody (95%CI: 30.6â€&quot;45.9). Co-infection of HIV/HBV was found"/>
 <result pre="co-infection was found in 29.5% (95%CI: 22.2â€&quot;36.8) of PWID. Triple" exact="infection" post="of HIV/HBV/HCV was identified in 9.2% (95%CI: 3.7â€&quot;14.7) of"/>
 <result pre="9.2% (95%CI: 3.7â€&quot;14.7) of PWID. Table 2 Prevalence of HIV," exact="hepatitis" post="and co-infections in PWID in two urban settings in"/>
 <result pre="0.09 1.2 0.6â€&quot;2.4 0.63 â€ƒNo 14/148 9.5 1 a Excluded" exact="female" post="participants b Other includes spoon, cotton or cleaning agent"/>
 <result pre="1.4â€&quot;3.9 1.3 0.7â€&quot;2.4 0.40 â€ƒNo 26/142 18.3 1 a Excluded" exact="female" post="participants b Other includes spoon, cotton or cleaning agent"/>
 <result pre="higher than prevalence rates estimated for PWID reported from sub-Saharan" exact="African" post="region for the three infections at 18.3, 3.7, 21.8%,"/>
 <result pre="for PWID reported from sub-Saharan African region for the three" exact="infections" post="at 18.3, 3.7, 21.8%, respectively [1]. Our prevalence of"/>
 <result pre="Maputo [13] and 9.1% of untreated HIV-infected adults [14]. The" exact="hepatitis" post="B vaccine was only introduced into the Mozambican national"/>
 <result pre="Although the HBV vaccine is not widely available for the" exact="adult" post="population, anti-retroviral therapy (ART) based-on tenofovir (TDF), lamivudine (3TC)"/>
 <result pre="(EFV) has dual treatment benefits for both HBV and HIV" exact="infections" post="[9, 12, 27]. The prevalence of HIV/HCV co-infection among"/>
 <result pre="evidence that HIV is associated with a higher risk of" exact="infection" post="with HCV due to the similar mode of transmission"/>
 <result pre="with age among HIV-infected individuals [31, 32]. Because HIV and" exact="viral hepatitis" post="are chronic and sometimes asymptomatic infections, it is likely"/>
 <result pre="age among HIV-infected individuals [31, 32]. Because HIV and viral" exact="hepatitis" post="are chronic and sometimes asymptomatic infections, it is likely"/>
 <result pre="HIV-infected individuals [31, 32]. Because HIV and viral hepatitis are" exact="chronic" post="and sometimes asymptomatic infections, it is likely that individuals"/>
 <result pre="and HIV/HCV, respectively. Other studies have found that HIV and" exact="hepatitis" post="transmission are associated with high-risk injection practices such as"/>
 <result pre="Individuals living with HIV/HCV co-infection are less likely to clear" exact="acute" post="HCV infection and more likely to transmit the virus"/>
 <result pre="with HIV/HCV co-infection are less likely to clear acute HCV" exact="infection" post="and more likely to transmit the virus which is"/>
 <result pre="healthcare services. Clients receive point-of-care screening for HIV, hepatitis, syphilis," exact="tuberculosis" post="and referrals for clinical care as needed [37]. However,"/>
 <result pre="treatment of STIs; prevention, diagnosis and treatment of TB and" exact="viral hepatitis" post="(B and C), risk reduction information and education for"/>
 <result pre="of STIs; prevention, diagnosis and treatment of TB and viral" exact="hepatitis" post="(B and C), risk reduction information and education for"/>
 <result pre="an integrated harm reduction package to prevent both HIV and" exact="hepatitis" post="infection among PWID, given their similar mode of transmission"/>
 <result pre="integrated harm reduction package to prevent both HIV and hepatitis" exact="infection" post="among PWID, given their similar mode of transmission via"/>
 <result pre="similar mode of transmission via sexual exposure and high-burden of" exact="infection" post="in specific populations [9, 36, 41]. Efforts to promote"/>
 <result pre="[42]. Although this represents the first analysis of HIV a" exact="viral hepatitis" post="among PWID in Mozambique, some limitations should be considered."/>
 <result pre="Although this represents the first analysis of HIV a viral" exact="hepatitis" post="among PWID in Mozambique, some limitations should be considered."/>
 <result pre="limitations should be considered. Given the low sample size, this" exact="secondary" post="analysis pooled results from the two survey cities resulting"/>
 <result pre="a prescription, which may have resulted in including participants with" exact="lower" post="recent risk of HIV and hepatitis infection. However, since"/>
 <result pre="in including participants with lower recent risk of HIV and" exact="hepatitis" post="infection. However, since most participants reported having injected during"/>
 <result pre="the HCV test (9.4% of the sample), perhaps due an" exact="absence of" post="point-of-care testing or treatment options within the national health"/>
 <result pre="the PWID BBS survey in Mozambique. The high burden of" exact="disease" post="among this population requires a enhance public health interventions"/>
 <result pre="population requires a enhance public health interventions since HIV and" exact="viral hepatitis" post="co-infection increases morbidity and mortality, as well changes the"/>
 <result pre="requires a enhance public health interventions since HIV and viral" exact="hepatitis" post="co-infection increases morbidity and mortality, as well changes the"/>
 <result pre="An integrated harm reduction strategy is necessary to address all" exact="infections" post="simultaneously. These services must be enhanced at health facilities"/>
 <result pre="improve their overall health status. Abbreviations ART Antiretroviral therapy Anti-HCV" exact="Hepatitis" post="C virus antibody BBS Biological and behavioral survey HBsAg"/>
 <result pre="Hepatitis C virus antibody BBS Biological and behavioral survey HBsAg" exact="Hepatitis" post="B surface antigen HBV Hepatitis B virus HCV Hepatitis"/>
 <result pre="Biological and behavioral survey HBsAg Hepatitis B surface antigen HBV" exact="Hepatitis" post="B virus HCV Hepatitis C virus HIV Human immunodeficiency"/>
 <result pre="HBsAg Hepatitis B surface antigen HBV Hepatitis B virus HCV" exact="Hepatitis" post="C virus HIV Human immunodeficiency virus PWID People who"/>
 <result pre="HBV Hepatitis B virus HCV Hepatitis C virus HIV Human" exact="immunodeficiency" post="virus PWID People who inject drugs RDS Respondent-driven sampling"/>
 <result pre="People who inject drugs RDS Respondent-driven sampling STI Sexual Transmitted" exact="Infections" post="Publisherâ€™s Note Springer Nature remains neutral with regard to"/>
 <result pre="Plan for AIDS Relief (PEPFAR) through the U.S. Centers for" exact="Disease" post="Control and Prevention (CDC) Mozambique Country Office under the"/>
 <result pre="two urban areas in MozambiqueBMC Infect Dis2019191102231791273 8.UmutesiJSimmonsBMakuzaJDDushimiyimanaDMbituyumuremyiAUwimanaJMet al.Prevalence of" exact="hepatitis" post="B and C infection in persons living with HIV"/>
 <result pre="MozambiqueBMC Infect Dis2019191102231791273 8.UmutesiJSimmonsBMakuzaJDDushimiyimanaDMbituyumuremyiAUwimanaJMet al.Prevalence of hepatitis B and C" exact="infection" post="in persons living with HIV enrolled in care in"/>
 <result pre="- a systematic review and meta-analysisPLoS One20163111(3) 10.Ray SaraswatiLSarnaASebastianMPSharmaVMadanIThiorIet al.HIV," exact="hepatitis" post="B and C among people who inject drugs: high"/>
 <result pre="among people who inject drugs: high prevalence of HIV and" exact="hepatitis C" post="RNA positive infections observed in Delhi, IndiaBMC Public Health20153015"/>
 <result pre="drugs: high prevalence of HIV and hepatitis C RNA positive" exact="infections" post="observed in Delhi, IndiaBMC Public Health20153015 11.ManshaSImranMShahAMUHJamalMAhmedFAtifMet al.Hepatitis B"/>
 <result pre="Delhi, IndiaBMC Public Health20153015 11.ManshaSImranMShahAMUHJamalMAhmedFAtifMet al.Hepatitis B and C virus" exact="infections" post="among human immunodeficiency virus-infected people who inject Drugs in"/>
 <result pre="Health20153015 11.ManshaSImranMShahAMUHJamalMAhmedFAtifMet al.Hepatitis B and C virus infections among human" exact="immunodeficiency" post="virus-infected people who inject Drugs in Lahore, PakistanViral Immunol201730536637028346804"/>
 <result pre="who inject Drugs in Lahore, PakistanViral Immunol201730536637028346804 12.ThorntonACJoseSBhaganiSChadwickDDunnDGilsonRet al.Hepatitis B," exact="hepatitis C," post="and mortality among HIV-positive individualsAIDS.201731182525253228926400 13.ViegasEOTembeNMacovelaEGonÃ§alvesEAugustoOIsmaelNet al.Incidence of HIV"/>
 <result pre="PakistanViral Immunol201730536637028346804 12.ThorntonACJoseSBhaganiSChadwickDDunnDGilsonRet al.Hepatitis B, hepatitis C, and mortality among" exact="HIV-positive" post="individualsAIDS.201731182525253228926400 13.ViegasEOTembeNMacovelaEGonÃ§alvesEAugustoOIsmaelNet al.Incidence of HIV and the prevalence of"/>
 <result pre="individualsAIDS.201731182525253228926400 13.ViegasEOTembeNMacovelaEGonÃ§alvesEAugustoOIsmaelNet al.Incidence of HIV and the prevalence of HIV," exact="hepatitis" post="B and syphilis among youths in Maputo, Mozambique: a"/>
 <result pre="of HIV and the prevalence of HIV, hepatitis B and" exact="syphilis" post="among youths in Maputo, Mozambique: a cohort studyPLoS One2015103e012145225798607"/>
 <result pre="Corte Real R, Mabunda N, Maueia C, et al. HBV" exact="infection" post="in untreated HIV-infected adults in Maputo, Mozambique. PLoS One."/>
 <result pre="PLoS One. 2017;31, 12(7). 15.WHO. Global health sector strategy on" exact="viral" post="sector strategy on viral hepatites 2016â€&quot;2021. Towards ending viral"/>
 <result pre="15.WHO. Global health sector strategy on viral sector strategy on" exact="viral" post="hepatites 2016â€&quot;2021. Towards ending viral hepatites 2016. Available from:"/>
 <result pre="on viral sector strategy on viral hepatites 2016â€&quot;2021. Towards ending" exact="viral" post="hepatites 2016. Available from: https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.Â Accessed 28 Feb 2020."/>
 <result pre="2030 agenda for sustainable development: - Resolution adopted by the" exact="General" post="Assembly on 25 September 2015. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld. Accessed"/>
 <result pre="Integrated Biological and Behavioral Survey among Mozambican Workers in South" exact="African" post="Mines, 2012; 2013. Available from:Â https://globalhealthsciences.ucsf.edu/sites/globalhealthsciences.ucsf.edu/files/pub/ibbs-mine-workers-final-report.pdf.Â Accessed 28 Feb"/>
 <result pre="I-TECH. Final report: the integrated biological and behavioral survey among" exact="female" post="sex workers, Mozambique 2011â€&quot;2012. Maputo: 2013.Â Available from: https://ins.gov.mz/sites/default/files/2019-11/IBBS-FSW-Final-Report.pdf.Â"/>
 <result pre="Ser A Stat Soc. 2015;178(1):241â€&quot;69. 10.1111/rssa.12059. 27.StabinskiLOÊ¼ConnorSBarnhartMKahnRJHammTEPrevalence of HIV and" exact="Hepatitis" post="B Virus Co-Infection in Sub-Saharan Africa and the Potential"/>
 <result pre="Sub-Saharan Africa and the Potential Impact and Program Feasibility of" exact="Hepatitis" post="B Surface Antigen Screening in Resource-Limited SettingsJ Acquir Immune"/>
 <result pre="Defic Syndr201568S274S28525768867 28.KlinglerCThoumiAIMrithinjayamVSCost-effectiveness analysis of an additional birth dose of" exact="hepatitis" post="B vaccine to prevent perinatal transmission in a medical"/>
 <result pre="34.Kilonzo SB, Gunda DW, Mpondo BCT, Bakshi FA, Jaka H." exact="Hepatitis" post="B virus infection in Tanzania: current status and challenges."/>
 <result pre="Gunda DW, Mpondo BCT, Bakshi FA, Jaka H. Hepatitis B" exact="virus infection" post="in Tanzania: current status and challenges. J Trop Med."/>
 <result pre="DW, Mpondo BCT, Bakshi FA, Jaka H. Hepatitis B virus" exact="infection" post="in Tanzania: current status and challenges. J Trop Med."/>
 <result pre="J Trop Med. 2018. 10.1155/2018/4239646. 35.ShapatavaENelsonKETsertsvadzeTdel RioCRisk behaviors and HIV," exact="hepatitis" post="B, and hepatitis C seroprevalence among injection drug users"/>
 <result pre="2018. 10.1155/2018/4239646. 35.ShapatavaENelsonKETsertsvadzeTdel RioCRisk behaviors and HIV, hepatitis B, and" exact="hepatitis C" post="seroprevalence among injection drug users in GeorgiaDrug Alcohol Depend200682Suppl"/>
 <result pre="2011 bio-behavioral study using respondent-driven samplingAIDS Behav201519Suppl 12435 39.ScheibeAYoungKMosesLBassonRLVersfeldASpearmanCWet al.Understanding" exact="hepatitis" post="B, hepatitis C and HIV among people who inject"/>
 <result pre="study using respondent-driven samplingAIDS Behav201519Suppl 12435 39.ScheibeAYoungKMosesLBassonRLVersfeldASpearmanCWet al.Understanding hepatitis B," exact="hepatitis C" post="and HIV among people who inject drugs in South"/>
 <result pre="country-level coverage of interventions to prevent and manage HIV and" exact="hepatitis C" post="among people who inject drugs: a systematic reviewLancet Glob"/>
</results>
